Pfizer Postpones EUA in Kids Under 5, will Wait for Full Data
Summary – -On the day the public and members of the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory…
Summary – -On the day the public and members of the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory…
It is not uncommon for different countries to require at least part of a clinical trial be conducted in their country. The…
Synopsis: The U.S. Food and Drug Administration announced it is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib). The drug…
Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…
A highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among…
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…
Summary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
Synopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…